Autoimmune lymphoproliferative syndrome surgery: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Autoimmune lymphoproliferative syndrome}} | {{Autoimmune lymphoproliferative syndrome}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 15: | Line 13: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 02:43, 6 July 2021
|
Autoimmune lymphoproliferative syndrome Microchapters |
|
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune lymphoproliferative syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome surgery |
|
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
|
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
No definitive surgery is required to treat Autoimmune lymphoproliferative syndrome(ALPS).
Surgery
Splenectomy is the only surgery used to treat ALPS. But splenectomy is reserved as the last treatment option in patients with severe refractory cytopenias, severe hypersplenism to avoid the high risk of recurrence cytopenias and sepsis in post-splenectomy patients with ALPS.[1]